Dana K. Furstenau

Reduction in vaso-occlusive events following stem cell transplantation in patients with sickle cell disease

Alexis Leonard, Dana K. Furstenau, Allistair Abraham et al. · Blood Advances · 2022 · 18 citations · Full text

Transplantation, Marrow Transplantation, Sickle Cell Disease +12

Vav2 protein overexpression marks and may predict the aggressive subtype of ductal carcinoma in situ

YunQing Jiang, Indira Prabakaran, Fei Wan et al. · Biomarker Research · 2014 · 15 citations · Full text

Ras-related protein 1 and the insulin-like growth factor type I receptor are associated with risk of progression in patients diagnosed with carcinoma in situ

Dana K. Furstenau, Nandita Mitra, Fei Wan et al. · Breast Cancer Research and Treatment · 2010 · 14 citations

Oncology, Ras-related Protein 1, Medicine +8

The small GTPase Rap1 promotes cell movement rather than stabilizes adhesion in epithelial cells responding to insulin-like growth factor I

Marina A. Guvakova, W. Lee, Dana K. Furstenau et al. · Biochemical Journal · 2014 · 13 citations

Ras-related Gtpase Rap1, Cell Adhesion, Cytoskeleton +19

Hydroxyurea to prevent brain injury in children with sickle cell disease (<scp>HU</scp> Prevent)—A randomized, placebo‐controlled phase <scp>II</scp> feasibility/pilot study

James F. Casella, Dana K. Furstenau, Robert J. Adams et al. · American Journal of Hematology · 2024 · 10 citations · Full text